Article

Sorry, but this supplement is no longer available

The supplement you are looking for is no longer available on-line.

The supplement you are looking for is no longer available on-line.

Please contact:

Associate Publisher


Marc DiBartolomeo
(732) 346-3032

mdibartolomeo@advanstar.com

Related Videos
Raveen Syan, MD, FPMRS, answers a question during a video interview
Jaspreet S. Sandhu, MD, answers a question during a video interview
J. Quentin Clemens, MD, MSCI, answers a question during a video interview
Timothy Lyon, MD, answers a question during a video interview
Anne Pelletier Cameron, MD, FRCSC, FPMRS, answers a question during a video interview
Related Content
Standard pathology reports may be difficult to understand for patients with prostate cancer
January 23rd 2025

Standard pathology reports may be difficult to understand for patients with prostate cancer

Hannah Clarke
Overall, 39% of those who received a university-formatted report and 56% of those who received a VA-formatted report were able to identify that they had prostate cancer.
Episode 2 Podcast: Managing Overactive Bladder: From Dual Diagnoses to Geriatric Challenges
January 14th 2025

Episode 2 Podcast: Managing Overactive Bladder: From Dual Diagnoses to Geriatric Challenges

Wayne Kuang, MD Steven Maislos, MD
Panelists discuss how managing overactive bladder in older adults requires a holistic approach that integrates treatment of comorbidities, emerging therapeutic options, and quality-of-life considerations to optimize patient outcomes.
Genomic tests may offer valuable prognostic insights, but clinical utility remains unclear
January 22nd 2025

Genomic tests may offer valuable prognostic insights, but clinical utility remains unclear

Hannah Clarke
"[The] full integration [of genomic classifier tests] into clinical practice requires additional research to better understand their cost-effectiveness, clinical utility, and impact on diverse populations," says Amir Alishahi Tabriz, MD, PhD, MPH.
Episode 1 Podcast: Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults
November 27th 2024

Episode 1 Podcast: Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults

Wayne Kuang, MD Bilal Chughtai, MD
Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.
ICG-guided technique improves surgical time, accuracy of PLND
January 21st 2025

ICG-guided technique improves surgical time, accuracy of PLND

Hannah Clarke
The accuracy of PLND was 93.41% in the ICG injection arm compared with 75.91% in the control arm.
Incorporating mpMRI in bladder cancer staging may improve time to treatment
January 21st 2025

Incorporating mpMRI in bladder cancer staging may improve time to treatment

Hannah Clarke
The median time to correct treatment was 98 days with initial TURBT vs 53 days with initial mpMRI.
© 2025 MJH Life Sciences

All rights reserved.